Literature DB >> 35771074

Multiple Subcutaneous 18F-FDG-avid Granulomas Due to Enoxaparin Injection.

Özge Erol Fenercioğlu1, Nurhan Ergül1, Ediz Beyhan1, Rahime Şahin1, Tevfik Fikret Çermik1.   

Abstract

A 67-year-old female patient with metastatic gastric adenocarcinoma was referred to 18fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) for restaging. PET/CT revealed liver metastasis and the patient received six-cycles of chemotherapy. On control 18F-FDG PET/CT the liver lesion disappeared but newly formed multiple foci of increased uptake in the subcutaneous adipose tissues of the abdominal wall were detected. The uptake was related to nodular lesions resulting from an idiosyncratic reaction to enoxaparin and from local trauma through repeated injections. ©Copyright 2022 by Turkish Society of Nuclear Medicine, Molecular Imaging and Radionuclide Therapy published by Galenos Yayınevi.

Entities:  

Keywords:  18F-FDG PET/CT; Enoxaparin; granuloma

Year:  2022        PMID: 35771074      PMCID: PMC9246302          DOI: 10.4274/mirt.galenos.2021.87487

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther        ISSN: 2146-1414


  3 in total

Review 1.  Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review.

Authors:  Inmaculada Alcaraz; Lorenzo Cerroni; Arno Rütten; Heinz Kutzner; Luis Requena
Journal:  Am J Dermatopathol       Date:  2012-06       Impact factor: 1.533

2.  Choroidal and cutaneous metastasis from gastric adenocarcinoma.

Authors:  Shoichiro Kawai; Tsutomu Nishida; Yoshito Hayashi; Hisao Ezaki; Takuya Yamada; Shinichiro Shinzaki; Masanori Miyazaki; Kei Nakai; Takayuki Yakushijin; Kenji Watabe; Hideki Iijima; Masahiko Tsujii; Kohji Nishida; Tetsuo Takehara
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

3.  Subcutaneous infiltrative nodule at the injection site of low-molecular weight heparin simulating malignancy.

Authors:  Daniel Val; José Val-Bernal
Journal:  Am J Dermatopathol       Date:  2014-05       Impact factor: 1.533

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.